At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 418 enrolled
Drug / intervention
Pitavastatin +1 moredrug
Likely dose
Pitavastatin 4 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Study of Pitavastatin Vs. Atorvastatin (Following Up-Titration) in Patients With Type II Diabetes Mellitus and Combined Dyslipidemia
In Brief
A Phase 3 clinical trial evaluating Pitavastatin and Atorvastatin for Type II Diabetes Mellitus and Dyslipidemia. Completed, enrolled 418 participants across 35 sites in 6 countries.
Detailed Summary
The purpose of this study is to compare the efficacy and safety of pitavastatin with that of atorvastatin in patients with type II diabetes mellitus (type II DM) and combined dyslipidemia.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType II Diabetes Mellitus, Dyslipidemia
CountriesDenmark, Germany, India, Netherlands, Poland, United Kingdom
Collaborators--
Timeline
Phase 3CompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartDec 2005
First PostedApr 2006
Primary CompletionJun 2007
TodayJul 2026
First PostedApr 3, 2006
Enrollment StartDec 1, 2005
Primary CompletionJun 1, 2007
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 20.2 years ago
Interventions
Pitavastatindrug
Pitavastatin 4 mg QD
Atorvastatindrug
Atorvastatin 20 mg